Literature DB >> 11257421

Uptake and efflux of the peptidic delta-opioid receptor agonist.

C Dagenais1, J Ducharme, G M Pollack.   

Abstract

P-glycoprotein (P-gp) and organic anion transporting polypeptides (Oatp) are expressed at the blood-brain barrier (BBB). There is little functional evidence for Oatp-mediated transport at the BBB. The peptidic delta opioid-receptor agonist [D-penicillamine(2,5)]-enkephalin (DPDPE) is a substrate of mdr1a P-gp and Oatp2. The present study evaluated the influence of these transporters on brain uptake of DPDPE by in situ perfusion in mice. Brain uptake was increased approximately 12-fold in mice lacking P-gp in the BBB, but the P-gp inhibitor dexverapamil did not increase uptake in P-gp-competent mice. In P-gp-deficient mice, DPDPE uptake was saturable (K(m) approximately 24 mM), and was inhibited by dexverapamil and the Oatp2 substrates digoxin, estradiol-17beta-glucuronide and fexofenadine. These results confirm P-gp-mediated efflux of DPDPE, and suggest functional uptake transport of DPDPE by Oatp, at the murine BBB.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11257421     DOI: 10.1016/s0304-3940(01)01640-8

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  15 in total

Review 1.  Targeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Ther Deliv       Date:  2011-08

Review 2.  Active efflux across the blood-brain barrier: role of the solute carrier family.

Authors:  Hiroyuki Kusuhara; Yuichi Sugiyama
Journal:  NeuroRx       Date:  2005-01

Review 3.  Peptides at the blood brain barrier: Knowing me knowing you.

Authors:  Thomas P Davis; Thomas J Abbruscato; Richard D Egleton
Journal:  Peptides       Date:  2015-04-30       Impact factor: 3.750

4.  Acetaminophen modulates P-glycoprotein functional expression at the blood-brain barrier by a constitutive androstane receptor-dependent mechanism.

Authors:  Lauren M Slosky; Brandon J Thompson; Lucy Sanchez-Covarrubias; Yifeng Zhang; Mei-Li Laracuente; Todd W Vanderah; Patrick T Ronaldson; Thomas P Davis
Journal:  Mol Pharmacol       Date:  2013-09-09       Impact factor: 4.436

5.  Inflammatory pain signals an increase in functional expression of organic anion transporting polypeptide 1a4 at the blood-brain barrier.

Authors:  Patrick T Ronaldson; Jessica D Finch; Kristin M Demarco; Colleen E Quigley; Thomas P Davis
Journal:  J Pharmacol Exp Ther       Date:  2010-12-02       Impact factor: 4.030

6.  Molecular Adsorbents Recirculating System dialysis in children with cholestatic pruritus.

Authors:  Betti Schaefer; Franz Schaefer; Dieter Wittmer; Guido Engelmann; Daniel Wenning; Claus Peter Schmitt
Journal:  Pediatr Nephrol       Date:  2011-11-15       Impact factor: 3.714

Review 7.  Pruritus in chronic liver disease: mechanisms and treatment.

Authors:  Nora V Bergasa
Journal:  Curr Gastroenterol Rep       Date:  2004-02

Review 8.  Targeted drug delivery to treat pain and cerebral hypoxia.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Pharmacol Rev       Date:  2013-01-23       Impact factor: 25.468

9.  Oxycodone induces overexpression of P-glycoprotein (ABCB1) and affects paclitaxel's tissue distribution in Sprague Dawley rats.

Authors:  Hazem E Hassan; Alan L Myers; Insong J Lee; Andrew Coop; Natalie D Eddington
Journal:  J Pharm Sci       Date:  2007-09       Impact factor: 3.534

Review 10.  Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development.

Authors:  Sumio Ohtsuki; Tetsuya Terasaki
Journal:  Pharm Res       Date:  2007-07-10       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.